- Home
- EDBL vs CNSP Comparison
EDBL vs CNSP Comparison
Compare EDBL & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EDBL | CNSP |
|---|---|---|
| Founded | 2020 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0M | 4.0M |
| IPO Year | 2022 | 2019 |
Fundamental Metrics
Financial Performance| Metric | EDBL | CNSP |
|---|---|---|
| Price | $1.21 | $7.50 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | ★ 66.7K | 14.1K |
| Earning Date | 11-14-2025 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $12,553,000.00 | N/A |
| Revenue This Year | $29.56 | N/A |
| Revenue Next Year | $20.00 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.05 | $4.93 |
| 52 Week High | $13.50 | $114.00 |
Technical Indicators
Market Signals| Indicator | EDBL | CNSP |
|---|---|---|
| Relative Strength Index (RSI) | 43.23 | 46.00 |
| Support Level | $1.05 | $6.62 |
| Resistance Level | $1.25 | $7.66 |
| Average True Range (ATR) | 0.12 | 0.60 |
| MACD | 0.01 | 0.06 |
| Stochastic Oscillator | 60.00 | 31.56 |
Price Performance
Historical ComparisonAbout EDBL Edible Garden AG Incorporated
Edible Garden AG Inc is a next-generation controlled environment agriculture farming company. It uses traditional agricultural growing techniques together with technology to grow fresh, organic food, sustainably and safely while improving traceability. The company uses the controlled environment of traditional greenhouse structures, such as glass greenhouses together with hydroponic and vertical greenhouses to sustainably grow organic herbs and lettuces.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.